Stocktoria
Neumora Therapeutics, Inc. NMRA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-09-15
Neumora Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,603,394 | $45.3M |
| MILLENNIUM MANAGEMENT LLC | 2,754,854 | $5.4M |
| TWO SIGMA INVESTMENTS, LP | 2,036,692 | $4.0M |
| RENAISSANCE TECHNOLOGIES LLC | 1,388,998 | $2.7M |
| Point72 Asset Management, L.P. | 602,403 | $1.2M |
| CITADEL ADVISORS LLC | 420,886 | $820,728 |
| AQR CAPITAL MANAGEMENT LLC | 55,995 | $109,189 |
Source: SEC EDGAR filings · CIK 0001885522 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.